Lamictal, also known by its generic name lamotrigine, is an anticonvulsant epilepsy prescription used to treat epilepsy and bipolar disorder.

Studies have suggested that there is a strong link between Lamictal use and Stevens Johnson Syndrome.

Lamictal (lamotrigine), manufactured by GlaxoSmithKline, was first approved by FDA in 1994 for the treatment of epilepsy and bipolar disorder.

Lamictal is available as a generic drug and there are several versions, including extended-release (Lamictal XR), an orally-disintegrating tablet (Lamictal ODT), and a chewable tablet (Lamictal CD).

What is Stevens Johnson Syndrome?

Stevens Johnson Syndrome (SJS) is a serious adverse skin reaction that is usually a reaction to a medication, such as Lamictal, that was recently started or taken.

It is accompanied by a rash and blisters where the skin in the affected areas dies and sloughs off. When more than 30 percent of the skin is involved Steven Johnson Syndrome is classified as Toxic Epidermal Necrolysis (TEN).

Both Lamictal Stevens Johnson Syndrome and Toxic Epidermal Necrolysis are medical emergencies that require immediate medical attention and often result in hospitalization.

SJS symptoms may include:

• A skin rash that turns red or purple
• Hives
• Skin pain
• Blisters in your mouth, nose, eyes and genitals

Before the rash develops in Stevens Johnson Syndrome, people often experience flu like symptoms, such as:

• Fever
• Sore mouth and throat
• Fatigue
• Cough
• Itching or Burning eyes

Lamictal SJS Warning

About 10 percent of patients who take Lamictal experience a rash on some area of their bodies. Even though most Lamictal-induced rashes are not severe, if patients develop Stevens Johnson Syndrome (SJS), they should immediately cease use of the drug.

Additionally, Lamictal carries an FDA Black Box Warning about the risk of life threatening skin reactions, including Stevens Johnson Syndrome, which is estimated to affect one in 1,000 adults and up to 1 in 50 children.

The warning indicates that signs of SJS are most likely to happen within the first two to eight weeks of Lamictal treatment. It also warns that children ages two to 16 are the most likely victims of Lamictal Stevens Johnson Syndrome.

Stevens Johnson Syndrome Lawsuits

Recovery from Stevens Johnson Syndrome and Toxic Epidermal Necrolysis can take months, and injuries can be permanent. They may include vision problems, sensitivity to light, scarring or discoloration of the skin, toenails and fingernails that do not grow back normally, sensitivity to the sun, increased sensitivity to temperatures, fertility problems, irritated and dry eyes, and internal organ damage. In the most severe cases, these SJS side effects can cause death.

If you or a loved one has been diagnosed with Stevens Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) or believe you have suffered permanent damage as a result of the harmful side effects of Lamictal, you may be entitled to compensation.